Delivery Order SPE2DB22D3016-SPE2DB25FAPJ8
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml. The contract has a ceiling value of $3,323.70 and a completion date of January 10, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,541.50 firm fixed-price contract is for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml to support military healthcare programs. The contract has an ultimate completion date of February 18, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply BYDUREON BCISE 2 MG AUTOINJECT 0.85ML medical products. The contract has a ceiling value of $21,160.09 and a period of performance through January 22, 2024. It is a firm fixed-price delivery order contract, with no set-aside requirements indicated. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,306.94, is for the supply of Bydureon BCISE 2 mg autoinjectors for the U.S. government. The contract is a firm fixed-price delivery order that runs through May 9, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Bydureon BCISE, a 2 mg auto-injectable medication. The contract has a firm fixed price and a ceiling value of $9,403.22. The delivery order was awarded on July 30, 2024, with a completion date of July 31, 2024. This contract is not set aside for any specific business type. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $60,352.77, is for the supply of Bydureon BCISE 2 mg auto-inject 0.85 ml syringes. The contract has a firm fixed price pricing type and an ultimate completion date of May 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company. The contract is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a type of pharmaceutical product. The contract has a ceiling value of $6,280.68 and a completion date of April 25, 2024. It is a Firm Fixed Price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML medication. The contract has a ceiling value of $3,140.40 and a performance period ending on August 19, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of...
This is a $6,464.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Bydureon BCISE 2 mg autoinjector medical devices, which are used for the treatment of diabetes. The contract has a performance period through February 26, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 MG Autoinjector 0.85 ML, a medication used in the treatment of diabetes. The contract has a ceiling value of $13,419.48 and a period of performance through April 20, 2023. The contract is a firm-fixed-price delivery order with no set-aside designation,...